Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-277621
Filing Date
2025-11-12
Accepted
2025-11-12 16:15:24
Documents
78
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A cycn-20241231.htm   iXBRL 10-K/A 1613081
2 EX-23.1 cycn-ex23_1.htm EX-23.1 11135
3 EX-31.1 cycn-ex31_1.htm EX-31.1 14718
4 EX-31.2 cycn-ex31_2.htm EX-31.2 14971
5 EX-32.1 cycn-ex32_1.htm EX-32.1 9140
6 EX-32.2 cycn-ex32_2.htm EX-32.2 9155
  Complete submission text file 0001193125-25-277621.txt   8865662

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cycn-20241231.xsd EX-101.SCH 1652538
80 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20241231_htm.xml XML 1567012
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38787 | Film No.: 251472926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)